S-Refit et al. close finance round for Lophius

All parties have previously invested in the firm. The capital will be used for market introduction of the T-Track CMV/EBV test applied in the field of transplantation, further development of a diagnostic test for the differential diagnosis of tuberculosis and development of a blood-based multiple sclerosis test.

The investor was attracted to the company as it has quickly developed from an academic researcher into a small diagnostics company.

Company
Regensburg-based Lophius Biosciences is a developer and marketer of T-cell-based test systems for diagnostics and possible therapy control in the fields of transplantation, infection, and autoimmune diseases.

People
Bertram Gilka-Bötzow managed the investment at S-Refit and Dr Caroline Fichtner is senior investment manager at High-Tech Gründerfonds.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Now researching
• Germany
• High-Tech Gründerfonds